Literature DB >> 36180703

Measuring the NQO2: Melatonin Complex by Native Nano-Electrospray Ionization Mass Spectrometry.

Jean A Boutin1,2, Johann Stojko3, Gilles Ferry3, Sarah Cianferani4,5.   

Abstract

Melatonin exerts its effects through a series of target proteins/receptors and enzymes. Its antioxidant capacity might be due to its capacity to inhibit a quinone reductase (NQO2) at high concentration (50 μM). Demonstrating the existence of a complex between a compound and a protein is often not easy. It requires either that the compound is an inhibitor-and the complex translates by an inhibition of the catalytic activity-or the compound is radiolabeled-and the complex translates in standard binding approaches, such as in receptology. Outside these two cases, the detection of the protein:small molecule complexes by mass spectrometry has recently been made possible, thanks to the development of so-called native mass spectrometry. Using this approach, one can measure masses corresponding to an intact noncovalent complex between a compound and its target, usually after titration or competition experiments. In the present chapter, we detail the characterization of NQO2:melatonin interaction using native mass spectrometry.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Co-substrate; Complex; Melatonin; NQO2; Native mass spectrometry

Mesh:

Substances:

Year:  2022        PMID: 36180703     DOI: 10.1007/978-1-0716-2593-4_34

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery.

Authors:  Catherine Vénien-Bryan; Zhuolun Li; Laurent Vuillard; Jean Albert Boutin
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-03-29       Impact factor: 1.056

Review 2.  NRH:quinone reductase 2: an enzyme of surprises and mysteries.

Authors:  Fanny Vella; Gilles Ferry; Philippe Delagrange; Jean A Boutin
Journal:  Biochem Pharmacol       Date:  2005-10-25       Impact factor: 5.858

3.  Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

Authors:  Q Zhao; X L Yang; W D Holtzclaw; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.

Authors:  Scott D Pegan; Megan Sturdy; Gilles Ferry; Philippe Delagrange; Jean A Boutin; Andrew D Mesecar
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

5.  Identification of the melatonin-binding site MT3 as the quinone reductase 2.

Authors:  O Nosjean; M Ferro; F Coge; P Beauverger; J M Henlin; F Lefoulon; J L Fauchere; P Delagrange; E Canet; J A Boutin
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.

Authors:  Kurt Benkestock; Per-Olof Edlund; Johan Roeraade
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

Review 7.  Melatonin as an antioxidant: under promises but over delivers.

Authors:  Russel J Reiter; Juan C Mayo; Dun-Xian Tan; Rosa M Sainz; Moises Alatorre-Jimenez; Lilian Qin
Journal:  J Pineal Res       Date:  2016-09-01       Impact factor: 13.007

8.  2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.

Authors:  M J Duncan; J S Takahashi; M L Dubocovich
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

9.  Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.

Authors:  Barbara Calamini; Bernard D Santarsiero; Jean A Boutin; Andrew D Mesecar
Journal:  Biochem J       Date:  2008-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.